Physician profile
Jack Lee Walzel
NPI 1093711012
$38,988.85
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $242 · 2020: $55.87 · 2021: $34K · 2022: $4,688 · 2023: $47.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $47.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $47.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $38,211.06 | 2021-2023 | Da Vinci Surgical System |
| Ethicon US, LLC | $186.85 | 2019-2021 | |
| Allergan, INC. | $140.18 | 2021 | |
| Endo Pharmaceuticals INC. | $103.10 | 2019-2021 | |
| Integra Lifesciences Corporation | $82.41 | 2021-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Mallinckrodt Enterprises LLC | $55.07 | 2019 | |
| W. L. Gore & Associates, INC. | $32.54 | 2021 | |
| Innocoll Pharmaceuticals Limited | $31.45 | 2021 | |
| Baxter Healthcare | $23.54 | 2019 | |
| Davol INC. | $15.93 | 2023 | Phasix Mesh |
| Tetraphase Pharmaceuticals, INC. | $15.44 | 2020 | |
| Kerecis Limited | $14.70 | 2022 | |
| Tactile Systems Technology INC | $13.89 | 2019 | |
| Conmed Corporation | $13.88 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $13.82 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $12.86 | 2022 | |
| Teleflex LLC | $11.25 | 2019 | |
| Acell, INC. | $10.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Walzel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.